Package 70771-1602-5

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70771-1602-5
Digits Only 7077116025
Product NDC 70771-1602
Description

5 VIAL in 1 CARTON (70771-1602-5) / 4 mL in 1 VIAL (70771-1602-1)

Marketing

Marketing Status
Marketed Since 2020-10-22
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f1081c30-3025-42ce-b222-824630689bb8", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["898316", "1665057"], "spl_set_id": ["cccf4a5f-6c5d-4d52-97e4-fe7a2dbd28d8"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (70771-1602-5)  / 4 mL in 1 VIAL (70771-1602-1)", "package_ndc": "70771-1602-5", "marketing_start_date": "20201022"}], "brand_name": "Verapamil Hydrochloride", "product_id": "70771-1602_f1081c30-3025-42ce-b222-824630689bb8", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70771-1602", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA214215", "marketing_category": "ANDA", "marketing_start_date": "20201022", "listing_expiration_date": "20261231"}